自然杀手细胞活动和对乳腺癌患者新辅助治疗的反应
Sofie Høier Gamborg-Kvist1,2, Else Maae1, Signe Timm1,2
1Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, 7100 Vejle, Denmark.
International journal of molecular sciences
|November 13, 2025
概括
自然杀手细胞活性 (NKA) 显示了乳腺癌患者的预后潜力. 低NKA与较差的无侵袭性疾病生存率有关,并且发现普雷尼索隆会损害NKA测量.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物标志物研究 生物标志物研究
背景情况:
- 缺乏用于监测新辅助乳腺癌治疗反应的有效生物标志物.
- 自然杀手细胞活性 (NKA) 在各种癌症中表现出预后价值.
研究的目的:
- 研究接受新辅助治疗的乳腺癌患者的NKA和治疗反应之间的关联.
- 评估NKA作为乳腺癌结果的潜在预后生物标志物.
主要方法:
- 血干扰素-玛 (IFNγ) 水平被测量为NKA的替代品.
- 血液样本在多个时间点收集:基线,治疗前和手术前/后.
- 研究的终点包括残留癌症负担 (RCB) 类,总生存率 (OS) 和无侵袭性疾病生存率 (IDFS).
主要成果:
- 术前低NKA与相对正常NKA (88.1%,p=0.049) 的相比,具有显著较低的无侵袭性疾病的五年生存率 (71.5%).
- 在第五 (p<0.0001) 和第六个治疗周期中,普雷尼索隆的使用显著抑制了血IFNγ水平.
- 不接受普得尼索隆治疗的患者的IFNγ水平显著更高,表明未受损的NKA测量.
结论:
- NKA有可能成为乳腺癌患者的预后生物标志物.
- 这项研究是第一个报告说,普得尼索隆干扰乳腺癌患者的NKA测量.
- 在评估NKA作为生物标志物时,仔细考虑像普得尼索隆这样的并发药物至关重要.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Cells of the Innate Immune Response
8.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
543
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
543


